The activation of human neutrophils by monosodium urate and calcium pyrophosphate dihydrate crystals is believed to play a critical role in the pathogenesis ofarthritides such as acute gout and pseudogout, respectively. In this study, we investigated the potential involvement of tyrosine phosphorylation in microcrystal-mediated activation of human neutrophils. Immunoblot analysis with antiphosphotyrosine antibodies demonstrated that triclinic monosodium urate and calcium pyrophosphate dihydrate crystals stimulated a time-and concentration-dependent tyrosine phosphorylation of at least five proteins (pp130, 118, 80, 70, and 60). While phosphoprotein (pp) 118 and pp7O were the major phosphorylated substrates, pp7O was the dominant one in reactivity with antiphosphotyrosine antibodies. When the temporal patterns, as well as the levels of tyrosine phosphorylation for both types of crystals were compared, monosodium urate crystals were found to be more potent activators than calcium pyrophosphate dihydrate crystals. The tyrosine phosphorylation patterns induced by microcrystals differed from those stimulated by other soluble (FMLP, C_%, or leukotriene B4) or particulate (unopsonized latex beads or zymosan) agonists which stimulated preferentially the tyrosine phosphorylation of ppl 18. The ratio of the intensities of ppl 18 and pp7O were specific of the stimulation with microcrystals when compared to those observed with the other soluble or particulate agonists. Colchicine, a drug used specifically in the treatment of gout and pseudogout, inhibited microcrystal-induced tyrosine phosphorylation, whileft-and y-lumicolchicine were without effect. On the other hand, colchicine failed to inhibit FMLP-induced tyrosine phosphorylation. Furthermore, while colchicine inhibited the activation of the NADPH oxidase by microcrystals, it, on the other hand, enhanced the production of superoxide anions by FMLP. Taken together, these results (a) demonstrate that tyrosine phosphorylation is involved in the mechanism of activation of human neutrophils induced by microcrystals; and (b) suggest, on the basis of the characteristics of the observed patterns of tyrosine phosphorylation, that this response may be specific to the microcrystals and relevant to their phlogistic properties. (J. Clin. Invest.
Introduction
Over the last 30 yr, several distinct microcrystals have been implicated in the pathogenesis of acute and chronic joint diseases. It is by now well established that the deposition ofmicrocrystalline monosodium urate monohydrate (MSU)' and calcium pyrophosphate dihydrate (CPPD) in joints and their interactions with neutrophils play an important role in the development of gouty arthritis and joint chondrocalcinosis (pseudogout), respectively ( 1, 2) . However, despite the fact that MSU and CPPD crystals are both involved in these inflammatory processes, they display differential phlogistic properties and metabolic responses, MSU crystals generally being more active than CPPD crystals (3) (4) (5) (6) (7) .
The activation of neutrophils by MSU and CPPD crystals results in the release ofinflammatory mediators that may be in part responsible for the local as well as the systemic inflammatory manifestations found in crystal-induced joint disorders. Interactions between crystals and neutrophils have been found to lead to the release of lysosomal enzymes (8, 9) and of a crystal-induced chemotactic factor ( 10, 11 ) , to stimulate the generation of oxygen derived free radicals (12, 13) , to induce phospholipase A2 enzyme activities and the synthesis ofa phospholipase A2 (PLA2) activating protein in leukocytes ( 14) , and to activate the synthesis of 5-lipoxygenase products ( 15 ) . Furthermore, it has recently been demonstrated that human neutrophils, monocytes, and synoviocytes can synthesize and release various cytokines such as IL-1, IL-6, and IL-8 in response to MSU and/or CPPD crystals (16) (17) (18) . However, little is known about the early intracellular signaling events that initiate and/or modulate these crystal-induced responses.
The addition of MSU and CPPD crystals to a suspension of human neutrophils leads to rapid increases in the cytoplasmic concentration of free calcium ( 15, 19) . Moreover, MSU-induced formation of inositol 1,4,5 trisphosphate has been demonstrated in neutrophils ( 19) . The mechanism ofactivation of phospholipase C (PLC) by microcrystals is presently unclear. In spite ofevidence indicating that the interaction ofMSU and CPPD with neutrophils stimulates a pertussis toxin (PT)-sensitive GTPase in purified membrane preparations (20) , several of the effects induced by MSU and CPPD crystals in intact neutrophils (calcium mobilization, superoxide production, phagocytosis, and phospatidylinositol 4,5-bisphosphate hydolysis) are only weakly sensitive or insensitive to PT (15, 20, 21) . These results indirectly suggest that the mechanisms of neutrophil activation by MSU and CPPD differ from those triggered in neutrophils by soluble chemotactic factors.
Recently, the presence of tyrosine-specific protein kinase activities has been demonstrated in neutrophils (22, 23) . Stimulation of intact human neutrophils with GM-CSF (24), chemotactic peptides such as FMLP (22, (25) (26) (27) , leukotriene B4 (27) , and platelet-activating factor (28) or with phorbol esters (26, 27) induces the rapid phosphorylation on tyrosine residues of several protein substrates. In addition, the results of recent studies have implicated the activation of tyrosine kinases in several neutrophil responses such as the oxidative burst (25) , and adherence and chemotaxis (29) .
The present study was thus undertaken to examine the potential involvement of tyrosine phosphorylation in the mediation of the activation of human neutrophils by inflammatory microcrystals. The results demonstrate that (a) microcrystals potently stimulate, in a colchicine-inhibitable manner, tyrosine phosphorylation in human neutrophils; (b) MSU crystals induce a more rapid and quantitatively more important tyrosine phosphorylation response than CPPD crystals; and (c) the pattern of tyrosine phosphorylation stimulated by microcrystals is characteristic in that it differs qualitatively from that observed in response to other neutrophil agonists (soluble or particulate).
Methods
Materials N-FMLP, zymosan, latex beads, and cytochrome C were obtained from Sigma Chemical Co. (St. Louis, MO). Ficoll-Paque and Dextran TSOO were obtained from Pharmacia (Dorval, Quebec, Canada). Leukotriene B4 and biosynthetic recombinant C5a were generous gifts from Dr. R. Young (Merck-Frosst, Dorval, Quebec, Canada) and H. J. Showell (Pfizer Central Research, Groton, CT), respectively. All stock solutions were made up in low endotoxin DMSO from Sigma Chemical Co. RPMI 1640 was from Gibco Laboratories (Grand Island, NY). The monoclonal antiphosphotyrosine antibody UB 05-321 was purchased from UBI (Lake Placid, NY). The enhanced chemiluminescence Western blotting system was obtained from Amersham Corp. (Arlington, IL).
Cell preparation. Blood was obtained from the peripheral vein of healthy adults in preservative-free citrate/phosphate/adenine anticoagulant solution. The neutrophils were sterilely obtained by means of6% dextran sedimentation followed by standard techniques of FicollPaque gradients and hypotonic lysis of erythrocytes. The cells were resuspended in RPMI 1640 medium, pH 7.4, at a final concentration of 15 x 106 cells/ml. The final cell preparations contained 2 98% neutrophils. Cell viability was measured by the release of lactate dehydrogenase activity and was 2 98% under all experimental conditions. Microcrystal preparation. MSU and CPPD crystals were prepared under sterile pyrogen-free conditions by modifications of previously described methods (30, 31 ) . Briefly, a boiling MSU solution (0.03 M, pH 7.5) was prepared by dissolution of equimolar quantities of uric acid and sodium hydroxide and filtered on an Acropor 3-pAm membrane filter (AN-3000; Gelman, Ann Arbor, MI). Sodium chloride (0.1 M final concentration) was added to speed up and improve the uniformity of the crystallization. CPPD was obtained by mixing a calcium nitrate solution (0.1 M final concentration) with an acidic solution of sodium pyrophosphate (final concentration 0.025 M in Na2P207 and 0.03 M HNO3). The milky-white precipitate formed CPPD crystals after a l-d incubation at 50-60'C.
All the crystals used in this study were characterized by x-ray diffraction (Geigerflex D/ max; Rigaku, Danvers, MA) and examination under phase and polarizing microscopy and scanning electron microscopy. The MSU and CPPD crystals showed triclinic morphologic characteristics. Their morphological properties, size, and specific area, determined by scanning microscopy and the BET method (32) , are depicted in Table I . Tyrosine phosphorylation. Freshly purified human neutrophils were incubated at 15 X 106 cells/ml for 5 min at 370C before stimulation for varying periods oftime with either MSU or CPPD crystals. The reactions were terminated by adding 60 ,d ofcell suspension to 60 til of boiling sample buffer (Tris HC1, pH 6.8, 2 mM Na orthovanadate, 10 mM nitrophosphate, 10 mM NaF, 10 mM pyrophosphate, 1 mM phenylmethylsulfonyl fluoride, 10 ug/ml leupeptin, 10 ,g/ml aprotinin, 20% SDS, 10% mercaptoethanol, 17.5% glycerol, and 0.1% bromophenol blue). The samples were denatured by boiling for 7 min at 100°C and loaded onto 7.5-20% SDS polyacrylamide gels. Electrophoretic transfer cells (Hoeffer Scientific Instruments, Canberra Packard, Canada, Mississauga, Ontario) were used to transfer proteins from the polyacrylamide gels to pdyvinyldene difluoride membranes (Immobilon; Millipore Corporation, Bedford, MA). Nonspecific sites were blocked using 2% gelatin in Tris-buffered saline (TBS)-Tween 0.1% (25 mM Tris HCI, pH 8.0, 190 mM NaCl, and 0.1% vol/vol Tween 20) for 1 h at 37°C. The monoclonal antibody UB 05-321 was then incubated with the membranes for 1 h at 37°C at a final dilution of 1:4,000 in 2% gelatin in TBS-Tween 0.1%. The membranes were washed three times at room temperature in TBS-Tween 0.1% and further incubated with a horseradish peroxidase-labeled sheep anti-mouse IgG (Amersham Corp.) for 1 h at 37°C at a final dilution of 1:20,000 in 2% gelatin in TBS-Tween 0.1%. The membranes were washed three times and the phosphotyrosine bands were revealed using the enhanced chemiluminescence Western blotting detection system. The molecular weights of the phosphotyrosine bands were estimated using a log plot of the migration of molecular weight standards.
Superoxide anion production. Superoxide anion production was monitored as the (superoxide dismutase-sensitive) reduction of cytochrome C as previously described (21 ). Briefly, neutrophil suspen- While similar profiles were detected in neutrophils stimulated with MSU or CPPD crystals, the temporal patterns and the levels of protein tyrosine phosphorylation did differ. MSUinduced tyrosine phosphorylation of all five substrates was detected within 2 min of stimulation, reached a maximum at 5 min and was maintained over a period of 15 min (Fig. 1 A) . A decline in the phosphorylation level of most of the substrates was observed 30 min after MSU treatment. A densitometric analysis of ppl 18 and pp7O showed a significant decrease in intensity of 81±6% (P < 0.05, n = 5) and 52±4% (P < 0.01, n = 5), between the 15-and 30-min time points, respectively. A significant decrease was also observed for the other tyrosine phosphorylated bands (data not shown). The decreases in tyrosine phosphorylation observed at later times were not caused by a cytotoxic effect ofthe crystals, since incubation of neutrophils with crystals for 60 min did not promote significant lactic dehydrogenase release from the cells (data not shown). In comparison, CPPD-induced tyrosine phosphorylation only reached maximal levels after 15 min of stimulation (Fig. I A) and remained constant for the next 45 min. A comparative densitometric analysis ofthe maximal levels ofCPPD-induced tyrosine phosphorylation showed that the intensities of tyrosine phosphorylation ofpp 1 18 and pp7O were only 44±15% (P < 0.05, n = 5) and 44±13% (P < 0.0l1, n = 5) ofthose induced by MSU microcrystals.
The concentration-dependence of the tyrosine phosphorylation induced by microcrystals was tested next after a 5-and 1 5-min incubation with MSU or CPPD crystals, respectively. Microcrystals stimulated detectable tyrosine phosphorylation in human neutrophils at concentrations . 0.3 mg/ml (Fig. 1  B) . A concentration-dependent increase in the labeling of all substrates was observed between 0.3 and 3 mg/ml.
The amino acid specificity of the crystal-stimulated phosphorylation as detected by immunoblot was tested by determining the ability of phosphoaminoacids to compete with the binding of the antibody to the blotted proteins. Whereas 50 mM phosphotyrosine eliminated the binding of the antiphosphotyrosine antibody to proteins from both control and crystal-stimulated cells, neither 50 mM phosphoserine nor 50 mM phosphothreonine had any significant effects (data not shown).
The variability among the physical characteristics of individual preparations ofMSU and CPPD crystals could affect the responsiveness of the cells. This possibility was examined by determining the tyrosine phosphorylation response of human neutrophils to several lots of triclinic MSU and CPPD crystals, significantly differing in size and specific area. The various crystal preparations were found to elicit essentially identical responses. However, the quantitative differences between the responses to MSU and CPPD crystals described above were consistently observed, whatever the size or the morphology of the crystals tested. In addition, potassium urate crystals were found to induce a similar pattern of tyrosine phosphorylation as MSU crystals. Finally, it was also observed that the addition of uric acid did not stimulate tyrosine phosphorylation (data not shown).
Effects of particulate agonists. To examine whether the MSU-and CPPD-induced tyrosine phosphorylation was a common feature ofthe responses ofhuman neutrophils to particulate agonists, two other particulate stimuli, unopsonized zymosan and latex beads, were also studied. In these experiments, neutrophils were stimulated for 15 min with 3 mg/ml of unopsonized zymosan, latex beads, MSU, or CPPD crystals. As can be seen in Fig. 2 , unopsonized latex beads and zymosan induced only a slight increase in the tyrosine phosphorylation of pp 1 18, while the inflammatory MSU and CPPD microcrystals, on the other hand, induced their characteristic responses (high pp7O/ppl 18 ratio). Hydroxy-apatite crystals ( 3 mg/ml) elicited a weak response that resembled that to latex beads or zymosan; i.e., a predominance ofthe 1 18-kD band (results not shown).
Effects ofsoluble agonists. The patterns of tyrosine phosphorylation induced by inflammatory microcrystals were compared next to those stimulated by soluble agonists. Neutrophils Figure 2 . Effects of particulate agonists on protein tyrosine phosphorylation. Neutrophils ( 15 X 106/ml) were incubated with 3 mg/ml of unopsonized zymosan, latex beads, MSU, or CPPD crystals for 15 min. Blotting and revelation ofthe phosphotyrosine bands were carried out as described under Methods.
were stimulated for 1 min with 10-7 M FMLP, LTB4, or C5a, a time at which it had previously been shown that maximal tyrosine phosphorylation in response to these agonists occurred. As demonstrated in Fig. 3 , the patterns of tyrosine phosphorylation induced by the soluble agonists differed from those obtained with MSU and CPPD crystals. Exposure of neutrophils to l0-7 M FMLP, C5a, or LTB4 stimulated principally the tyrosine phosphorylation ofa major protein with a molecular mass -I 1 8 kD, and to a minor extent that ofthe 130, 90, 60, and 70 kD proteins (Fig. 3) . While the addition of the microcrystals also resulted in the tyrosine phosphorylation ofppl 18, they, as previously shown, stimulated to a much greater extent that of pp70.
Effect ofcolchicine on crystal-induced tyrosine phosphorylation. The effects of colchicine on the tyrosine phosphorylation induced by microcrystals were tested next. Neutrophils were preincubated for 1 h with 10 ,uM colchicine or with its inactive analogs fi-or y-lumicolchicine. The cells were further stimulated with 3 mg/ ml MSU or CPPD crystals and a densitometric analysis of the levels of four of the major phosphotyrosine bands were performed (Table II) for colchicine-treated cells, while a representative immunoblot illustrates the effects of the three alkaloids on MSU-induced tyrosine phosphorylation (Fig. 4) . It is noteworthy that the 1 h preincubation at 37°C resulted in a shift in the optimal stimulation time from 30 to 45 min (as compared to 5 and 15 min without preincubation) for MSU and CPPD crystals, respectively. Colchicine by itself, increased to a small extent the levels of phosphorylation of pp60, pp7O, and pp 118 in control cells, but inhibited the tyrosine phosphorylation induced by both MSU and CPPD microcrystals. Densitometric analysis indicated that the stimulation of tyrosine phosphorylation of ppl 18 and of pp7O was inhibited by > 60% by colchicine for both MSU and CPPD crystals and that of ppl30 and pp6O by > 55% for MSU and > 30% for CPPD (Table II) . Although inhibited, the densitometric analysis of pp8O was not performed because of its proximity to pp7O. The specificity ofthe effects ofcolchicine on the crystal-induced tyrosine phosphorylation was confirmed by the failure of the inactive analogs of colchicine, fi-and y-lumicolchicine, to inhibit MSU- (Fig. 4) or CPPD-(data not shown) induced tyrosine phosphorylation. The stimulus-specific effect ofcolchicine was confirmed by its inability to inhibit the FMLP-induced tyrosine phosphorylation (Fig. 5) . Pretreatment ofneutrophils with colchicine did, however, increase the tyrosine phosphorylation ofthe pp6O and pp7O in response to FMLP. A densitometric analysis ofthe FMLP-induced tyrosine phosphorylation showed a 1.9-and 3.3-fold increase for the pp6O and pp7O proteins, respectively (Table II) .
Effect ofcolchicine on microcrystal-andFMLP-induced superoxide anion production. Neutrophils were preincubated for 1 h with 10 ,M colchicine or its diluent (DMSO). The cells were then further stimulated either with 3 mg/ml MSU or CPPD crystals for 15 min or with 10-7 M FMLP for 5 min. The amounts of superoxide anion produced during this time in untreated or colchicine-treated neutrophils were then measured. While pretreatment of neutrophils with colchicine inhibited crystal-induced superoxide production, it, on the other hand, enhanced that induced by FMLP (Fig. 6 ).
Discussion
We have observed that inflammatory microcrystals stimulate tyrosine phosphorylation in human neutrophils. In addition to 1652 Gaudry, Roberge Figure 4 . Effects of colchicine, fl-and y-lumicolchicine on MSU-induced tyrosine phosphorylation.
Neutrophils (15 x 106/ ml) were incubated for 1 h with 10 ,uM colchicine, fl-or -y-lumicolchicine, and then stimulated with 3 mg/ml MSU crystals for 30 min. Blotting and revelation of the phosphotyrosine bands were carried out as described under Methods.
demonstrating for the first time the stimulation of this signaling pathway by MSU and CPPD crystals, these results also provide evidence that this response is characteristic of these stimuli, and that it can be distinguished from that induced by other particulate or soluble neutrophil agonists. The addition ofMSU and CPPD crystals to human neutrophils caused a time-and concentration-dependent increase in the tyrosine phosphorylation level of at least five major proteins, ppl30, ppl 18, pp8O, pp7O, and pp6O (Fig. 1, A and B) . The pp 118 and pp7O consistently showed the greatest increases, the pp70 being the major phosphorylated substrate in response to the crystals (Fig. I A) . The tyrosine phosphorylation response to MSU crystals was more rapid and more pronounced than that induced by CPPD crystals. Thus, the relative abilities of the microcrystals to stimulate tyrosine phosphorylation in human neutrophils parallel their phlogistic (22, 25, 26, 29) , platelet-activating factor (28), leukotriene B4 (27) , and cytokines (24) has previously been shown to be associated with increased tyrosine phosphorylation. These results suggest that tyrosine phosphorylation may play important roles in the activation of neutrophils, a suggestion strengthened by the ability of tyrosine kinase inhibitors to inhibit the chemotactic factor-stimulated locomotory and adherence responses of the cells (29) , generation of superoxide anions (25) , and activation of phospholipase D (34a). Previous reports have demonstrated that MSU and CPPD crystals activate the excitation-coupling sequence of human neutrophils (increase in intracytoplasmic calcium ( 15, 20, 21 ) and leukotriene synthesis ( 15 ) among others) in a manner suggesting the involvement of certain common transductional pathways between microcrystals and soluble or particulate agonists. On the other hand, the interactions between microcrystals and human neutrophils have been found to be significantly less sensitive to inhibition by pertussis toxin than those initiated by chemotactic factors (20, 21 ) . The distinctive patterns of tyrosine phosphorylation induced by microcrystals and soluble agonists observed in the present study further indicate that qualitative differences exist between the mechanism ofactivation ofhuman neutrophils by these two classes ofstimuli. The present results are both more direct and of significant additional relevance to the functional status of the cells than those based on inhibitor studies.
The relevance of the microcrystal-induced tyrosine phosphorylation to the mechanism of neutrophil activation is underlined by the effects of colchicine on crystal and FMLP-induced tyrosine phosphorylation and production of superoxide anions. Colchicine is unique among therapeutic agents used in the treatment of acute gout and pseudogout, in that its usefulness is generally felt to be relatively limited to these rheumatic diseases (35) . The ability of colchicine (but not of its inactive analogs) to specifically inhibit microcrystal-induced tyrosine phosphorylation and the parallel effects of colchicine on tyrosine phosphorylation and on superoxide anion generation (Figs. 4-6 ) provide additional support for the hypothesis that the latter response is linked to the phlogistic properties of microcrystals. It is important, however, to point out that a causative link between these two responses is only suggested but not established by the data at hand. Although the precise mechanism of action ofcolchicine has remained elusive ( 14, 36) , the present results suggest a novel putative site ofaction by demonstrating that the alkaloid interferes either with one or more elements of the activation pathways used by microcrystals or directly with a specific subset of tyrosine kinases. The elucidation ofthe biochemical mechanisms by which colchicine exerts its inhibitory effect on crystal-induced tyrosine phosphorylation and to a larger extent on crystal-induced neutrophil activation while of significant basis and clinical interest, is, however, not directly relevant to the aim of the present study.
While the present study provides strong evidence for a role oftyrosine phosphorylation in crystal-induced neutrophil activation, the key to understanding the details of signal transduction pathways is likely to lie in the identification of the phosphotyrosine substrates detected in neutrophils stimulated by MSU and CPPD crystals. The nature ofthe predominant phosphotyrosine band, pp7O, remains unknown. Among the potential substrates, ribosomal S6 kinase (70 kD) is an attractive candidate, since it has been shown to be one, among others, of the PDGF-induced phosphorylated substrate (37) . In addition, Raf-1, a 74-kD protein, has been reported to be implicated as an intermediate in signal transduction mechanisms (38) . While five major substrates were reported in this study, a colchicine-sensitive band of an apparent molecular mass of -100 kD was found phosphorylated under most ofthe microcrystals experimental conditions tested. Recent reports have shown that MSU crystals stimulate PLA2 activity and induce the activity of PLA2-activating protein ( 14) , two crystal-induced responses found to be inhibited by colchicine. Since a PLA2 of an apparent molecular weight of 100 kD has been recently cloned in the human monoblast U937 cells (39), a colchicine-sensitive PLA2 could be an attractive substrate for the pp O00 described in this study.
In summary, the results of the present investigation have uncovered a biochemical response, the specificity and characteristics ofwhich make it likely that it is ofsignificant relevance to the interactions between microcrystals and human neutrophils. Furthering our understanding ofthe stimulation oftyrosine phosphorylation by microcrystals (nature and mechanism of activation of the kinases and/or phosphatases involved, as well as the identification of the substrates and their physiological functions) will lead to a significantly improved understanding of neutrophil physiology and potentially to more efficient strategies to control the associated inflammatory reactions.
